Here are three insights:
1. The requirement seeks to warn both providers and patients about the link between painkillers and overdoses.
2. The new policy requires painkillers like oxycodone to have labels warning of “misuse, abuse, addiction, overdose and death.”
3. Commissioner Califf said the policy isn’t only targeting drug companies, but providers who may prescribe more opioids than they should.
More spine news:
Orthopaedic Research Society awards Dr. James Chappuis & team best poster: 5 key notes
Titanium vs. cobalt-chrome for scoliosis growing rods: 5 key notes
Dr. Praveen Kadimcherla advises on spinal arthritis: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.